MARKET

ARWR

ARWR

Arrowhead Pharma
NASDAQ
62.64
-1.88
-2.91%
Closed 19:00 02/09 EST
OPEN
64.67
PREV CLOSE
64.52
HIGH
65.09
LOW
61.45
VOLUME
5.84M
TURNOVER
22.33M
52 WEEK HIGH
76.76
52 WEEK LOW
9.57
MARKET CAP
8.77B
P/E (TTM)
40.65
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARWR last week (0202-0206)?
Weekly Report · 23h ago
Arrowhead Pharmaceuticals Earnings Call Flags Pivotal 2026
TipRanks · 2d ago
Arrowhead Pharmaceuticals (ARWR) Q1 Profit Challenges Bearish Narratives On Earnings Quality
Simply Wall St · 2d ago
Arrowhead price target lowered to $78 from $81 at Morgan Stanley
TipRanks · 3d ago
Arrowhead (ARWR) Q1 2026 Earnings Call Transcript
The Motley Fool · 3d ago
Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Envista Holdings (NVST)
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN) and Rigel (RIGL)
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)
TipRanks · 3d ago
More
About ARWR
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, muscle and central nervous system. It has around 16 clinical-stage investigational medicines (wholly owned and partnered), which range in development stage from Phase I to Phase III. The Company's pipeline products include Plozasiran, Zodasiran, Olpasiran, ARO-RAGE, ARO-MMP7, GSK-4532990, Fazirsiran, GSK5637608, ARO-CFB, ARO-INHBE, ARO-C3, ARO-PNPLA3, ARO-DUX4, ARO-DM1 and ARO-ATXN2.

Webull offers Arrowhead Pharmaceuticals Inc stock information, including NASDAQ: ARWR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARWR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARWR stock methods without spending real money on the virtual paper trading platform.